Supplemental Table 1. Table of outcomesSupplemental Table 2. Testosterone levels between those who were affected by the change in target testosterone levels and those who were not. Supplemental Table 3. Adverse Events After 18 Months of Testosterone Therapy</div
<p> Supplemental Material, Table_S3 for Comparison of Serious Adverse Event Profiles Among...
Supplementary Table 1. Change from Baseline in Efficacy and Safety Parameters over Two Years of Oral...
Supplementary Table S3: Temporally significant metabolites from DMSO treatment as determined by t-t...
Supplemental Table 2. Testosterone levels between those who were affected by the change in target te...
Supplementary Figures for Manuscript Titled "Selective loss of levator ani and leg muscle volumes in...
Supplementary Table 1 – this table lists the change scores for clinical outcome measures and strengt...
Additional file 1: Supplemental Table 1. Linear regression of quintiles of dietary cholesterol and s...
Supplemental material, Supplemental_tables_1_and_2 for Adverse Drug Events as a Reason for Adult Hos...
Additional file 1: Supplemental Table. All International Classifications of Disease (ICD), ninth and...
Supplemental Tables 1 and 2 from: Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism i...
Supplemental material, Supplementary_table for Pituitary as a Source of HCG: Residual Levels After B...
<p>*P<0.05 vs. sham group.</p>△<p>P<0.05 vs. model group.</p><p>The effects of different treatments ...
<p>Supplemental material, Supplementary tables for Altered Cortical Gamma-Amino Butyric Acid in Fema...
(A) Total testosterone (TT) levels, (B) Free testosterone (FT) levels and (C) Sex hormone-binding gl...
These are the two supplementary tables for the article "Quality of life in patients with hypoparathy...
<p> Supplemental Material, Table_S3 for Comparison of Serious Adverse Event Profiles Among...
Supplementary Table 1. Change from Baseline in Efficacy and Safety Parameters over Two Years of Oral...
Supplementary Table S3: Temporally significant metabolites from DMSO treatment as determined by t-t...
Supplemental Table 2. Testosterone levels between those who were affected by the change in target te...
Supplementary Figures for Manuscript Titled "Selective loss of levator ani and leg muscle volumes in...
Supplementary Table 1 – this table lists the change scores for clinical outcome measures and strengt...
Additional file 1: Supplemental Table 1. Linear regression of quintiles of dietary cholesterol and s...
Supplemental material, Supplemental_tables_1_and_2 for Adverse Drug Events as a Reason for Adult Hos...
Additional file 1: Supplemental Table. All International Classifications of Disease (ICD), ninth and...
Supplemental Tables 1 and 2 from: Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism i...
Supplemental material, Supplementary_table for Pituitary as a Source of HCG: Residual Levels After B...
<p>*P<0.05 vs. sham group.</p>△<p>P<0.05 vs. model group.</p><p>The effects of different treatments ...
<p>Supplemental material, Supplementary tables for Altered Cortical Gamma-Amino Butyric Acid in Fema...
(A) Total testosterone (TT) levels, (B) Free testosterone (FT) levels and (C) Sex hormone-binding gl...
These are the two supplementary tables for the article "Quality of life in patients with hypoparathy...
<p> Supplemental Material, Table_S3 for Comparison of Serious Adverse Event Profiles Among...
Supplementary Table 1. Change from Baseline in Efficacy and Safety Parameters over Two Years of Oral...
Supplementary Table S3: Temporally significant metabolites from DMSO treatment as determined by t-t...